California just inched closer to asking voters for a massive bet on homegrown science, and UCSF researchers are watching like their jobs depend on it. On Wednesday, state lawmakers cleared Senate Bill 895 in a 29-9 vote, advancing a plan to create a state research foundation and, as amended, to put a $12 billion science bond on the November ballot. UCSF researchers say the money could serve as a crucial backstop for projects, staff and clinical trials that have been stalled by delays or freezes in federal grants. The stakes in San Francisco are obvious: research jobs, patient trials and community partnerships may now hinge on what Sacramento does next.
The Senate passed SB 895 by that 29-9 margin and sent it to the Assembly, according to Sen. Scott Wiener’s office. Supporters say that if the Assembly signs off and the governor approves the measure, voters will make the final call on the bond in the statewide November election.
The bill’s current, amended language would authorize $12 billion in bonds instead of the $23 billion figure initially floated earlier this year, as reflected in the official bill text on LegiInfo. The University of California had originally pushed for that larger $23 billion package..
Backers argue the measure is urgent because federal research dollars have slowed to a crawl. The Association of American Medical Colleges found that the NIH had obligated $5.8 billion by March 20, about 34 percent less than at the same point in FY2024, a shortfall that supporters say is already triggering layoffs and the pause of projects. UCSF officials told Mission Local that NIH grants account for roughly one-third of the university’s research funding, and that clinical trials and community partners have already felt the impact.
What the bond would fund
SB 895 would set up the California Foundation for Science and Health Research to award competitive grants and low-interest loans, modernize aging lab facilities and support work on priorities such as pandemic preparedness, wildfire resilience and behavioral health. The proposal also includes what supporters describe as first-in-the-nation provisions aimed at lowering drug prices, including requirements for discounts on pharmaceuticals developed with bond funding, reclaiming a portion of licensing revenue and allowing public production through CalRx, according to Sen. Scott Wiener’s office.
Political and fiscal hurdles
Even with strong institutional backing from the UC system and major unions, the bond is far from a slam dunk. Mission Local reported that all nine Senate "no" votes came from Republicans, and lawmakers will still have to balance this proposal against competing spending demands. The Legislative Analyst’s Office has warned of long-term structural pressures on the state budget even as revenues improved in the May revision, a backdrop that could make both legislators and voters wary of taking on a large new borrowing plan, according to the Legislative Analyst’s Office.
What’s next
SB 895 now heads to the Assembly, where supporters will be working the halls to lock in votes before key deadlines that determine whether measures qualify for the November ballot, as reflected in the legislative calendar and the Senate Daily File. If the Assembly approves the bill and the governor signs it, the bond would then land in voters’ hands. UC, UAW and campus researchers say they plan to keep organizing to argue that state investment is essential while federal awards remain unpredictable.
